fda semaglutide approval ๐Exciting news that is now approved for MASH (aka fatty liver disease) โAt week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Kids approved for weight loss
Description
Semaglutide exposure was associated with a higher incidence rate (0228 vs

Cigna may cover Zepbound with prior authorization
Hims Faces Lawsuit Over Knockoff Wegovy and Novo Nordisk Split July 21, 2025  

GLP-1 Is Not JUST a Weight-Loss Drug

The percentage of U.S